By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Roxane Laboratories, Inc. 

P.O. Box 16532

Columbus  Ohio  43216  U.S.A.
Phone: 800-962-8364 Fax: 614-308-3540


SEARCH JOBS


Industry
Services






Company News
Shire plc Files Lawsuits Against Watson Pharmaceuticals, Inc. (WPI) and Roxane Laboratories, Inc. for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents 7/7/2011 6:18:40 AM
Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets 10/7/2010 10:58:37 AM
Roxane Laboratories, Inc. Announces the Launch of Naratriptan Tablets USP 7/9/2010 8:53:18 AM
Roxane Laboratories, Inc. Announces the Abbreviated New Drug Application Approval of Valacyclovir Hydrochloride Tablets 500mg and 1g 6/10/2010 8:38:54 AM
Roxane Laboratories, Inc. Announces the Launch of Imipramine Pamoate Capsules 4/19/2010 10:06:56 AM
Roxane Laboratories, Inc. Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 1/27/2010 8:12:58 AM
Roxane Laboratories, Inc. Announces the Launch of Galantamine Hydrobromide Oral Solution 8/25/2009 10:43:41 AM
Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL 7/30/2009 9:50:03 AM
Roxane Laboratories, Inc. Announces the Launch of Mycophenolate Mofetil 250mg Capsules and 500mg Tablets 5/4/2009 11:21:43 AM
Roxane Laboratories, Inc. Announces the Launch of Levetiracetam Tablets and Oral Solution 1/16/2009 9:30:32 AM
1234
//-->